Literature DB >> 23265686

Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems.

Fabrizio Benedetti1, Wilma Thoen, Catherine Blanchard, Sergio Vighetti, Claudia Arduino.   

Abstract

Pain is a negative emotional experience that is modulated by a variety of psychological factors through different inhibitory systems. For example, endogenous opioids and cannabinoids have been found to be involved in stress and placebo analgesia. Here we show that when the meaning of the pain experience is changed from negative to positive through verbal suggestions, the opioid and cannabinoid systems are co-activated and these, in turn, increase pain tolerance. We induced ischemic arm pain in healthy volunteers, who had to tolerate the pain as long as possible. One group was informed about the aversive nature of the task, as done in any pain study. Conversely, a second group was told that the ischemia would be beneficial to the muscles, thus emphasizing the usefulness of the pain endurance task. We found that in the second group pain tolerance was significantly higher compared to the first one, and that this effect was partially blocked by the opioid antagonist naltrexone alone and by the cannabinoid antagonist rimonabant alone. However, the combined administration of naltrexone and rimonabant antagonized the increased tolerance completely. Our results indicate that a positive approach to pain reduces the global pain experience through the co-activation of the opioid and cannabinoid systems. These findings may have a profound impact on clinical practice. For example, postoperative pain, which means healing, can be perceived as less unpleasant than cancer pain, which means death. Therefore, the behavioral and/or pharmacological manipulation of the meaning of pain can represent an effective approach to pain management.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23265686     DOI: 10.1016/j.pain.2012.11.007

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  29 in total

Review 1.  Studying placebo effects in model organisms will help us understand them in humans.

Authors:  Simon C Harvey; Chris J Beedie
Journal:  Biol Lett       Date:  2017-11       Impact factor: 3.703

Review 2.  Pain and the context.

Authors:  Elisa Carlino; Elisa Frisaldi; Fabrizio Benedetti
Journal:  Nat Rev Rheumatol       Date:  2014-02-25       Impact factor: 20.543

3.  Transforming Pain With Prosocial Meaning: A Functional Magnetic Resonance Imaging Study.

Authors:  Marina López-Solà; Leonie Koban; Tor D Wager
Journal:  Psychosom Med       Date:  2018 Nov/Dec       Impact factor: 4.312

Review 4.  Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons.

Authors:  Scott M Schafer; Stephan Geuter; Tor D Wager
Journal:  Prog Neurobiol       Date:  2017-11-03       Impact factor: 11.685

Review 5.  Therapeutic Basis of Clinical Pain Modulation.

Authors:  Daniel R Kirkpatrick; Dan M McEntire; Zakary J Hambsch; Mitchell J Kerfeld; Tyler A Smith; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-05-11       Impact factor: 4.689

6.  Impaired mesocorticolimbic connectivity underlies increased pain sensitivity in chronic low back pain.

Authors:  Siyi Yu; Wen Li; Wei Shen; Robert R Edwards; Randy L Gollub; Georgia Wilson; Joel Park; Ana Ortiz; Jin Cao; Jessica Gerber; Ishtiaq Mawla; Suk-Tak Chan; Jeungchan Lee; Ajay D Wasan; Vitaly Napadow; Ted J Kaptchuk; Bruce Rosen; Jian Kong
Journal:  Neuroimage       Date:  2020-05-18       Impact factor: 6.556

Review 7.  Psychosocial factors and central sensitivity syndromes.

Authors:  Leah M Adams; Dennis C Turk
Journal:  Curr Rheumatol Rev       Date:  2015

8.  Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review.

Authors:  Laura Colino; Javier Herranz-Herrer; Elena Gil-Benito; Teresa Ponte-Lopez; Pablo Del Sol-Calderon; Maria Rodrigo-Yanguas; María Gil-Ligero; Antonio J Sánchez-López; Jose de Leon; Hilario Blasco-Fontecilla
Journal:  Curr Psychiatry Rep       Date:  2018-03-15       Impact factor: 5.285

Review 9.  Placebo and the new physiology of the doctor-patient relationship.

Authors:  Fabrizio Benedetti
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

10.  Use of the cross-translational model to study self-injurious behavior in human and nonhuman primates.

Authors:  Melinda A Novak; Saif N El-Mallah; Mark T Menard
Journal:  ILAR J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.